tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market

Kairos Pharma, Ltd. (KAPA) Financial Statements

Compare
46 Followers

Kairos Pharma, Ltd. Financial Overview

Kairos Pharma, Ltd.'s market cap is currently ―. The company's EPS TTM is $-0.213; its P/E ratio is ―; Kairos Pharma, Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -1.71M$ -571.00K$ -1.94M$ -1.05M
EBITDA$ -1.55M$ -431.00K$ -1.88M$ -1.05M
Net Income$ -1.81M$ -1.05M$ -2.15M$ -1.05M
Balance Sheet
Cash & Short-Term Investments$ 93.00K$ 437.00K$ 73.00K$ 14.31K
Total Assets$ 965.00K$ 1.04M$ 775.00K$ 14.31K
Total Debt$ 0.00$ 582.00K$ 380.00K$ 50.00K
Net Debt$ -93.00K$ 145.00K$ 307.00K$ 35.69K
Total Liabilities$ 1.59M$ 2.21M$ 1.94M$ 357.15K
Stockholders' Equity$ -626.00K$ -1.18M$ -1.17M$ -342.84K
Cash Flow
Free Cash Flow$ 81.00K$ -353.00K$ -412.00K$ -38.53K
Operating Cash Flow$ 81.00K$ -353.00K$ -412.00K$ -38.53K
Investing Cash Flow$ 0.00$ 0.00$ -109.00K$ 0.00
Financing Cash Flow$ -425.00K$ 717.00K$ 580.00K$ 37.00K
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History

Kairos Pharma, Ltd. Debt to Assets

Kairos Pharma, Ltd. Cash Flow

Kairos Pharma, Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis